
    
      Each individual subject's participation is scheduled to last approximately two years.
      Patients will be given Gardasil injections at months 0, 2, and 6. Patients will have
      geometric mean titers (GMT) measured at 7, 12, and 24 months. Questionnaires about health and
      function will also be completed at each visit.
    
  